Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Part I. General subjects
-
1. Need for drug delivery systems 1
- Prof. Ana Catarina Silva
-
2. Need for drug delivery systems 2
- Prof. João Nuno Moreira
-
3. Routes of drug delivery
- Prof. Dr. Sven Stegemann
-
4. Transporters in drug delivery
- Dr. Pravin Shende
-
5. The theory and applications of controlled release principles
- Dr. Michael J. Rathbone
- Part II. Routes for drug delivery
-
6. Oral drug delivery
- Dr. Vineet Kumar Rai
-
7. Transdermal drug delivery
- Prof. Sabine Szunerits
-
8. Pulmonary drug delivery
- Prof. Anthony J. Hickey
-
9. Gastrointestinal drug delivery
- Prof. Susan Hua
-
10. Mucoadhesive drug delivery systems
- Dr. Panoraia I. Siafaka
-
11. Ocular drug delivery
- Prof. Emily Dosmar
-
12. Vaginal and uterine drug delivery
- Prof. José Luis Arias Mediano
-
13. Drug-eluting implants
- Dr. Aliasger K. Salem
- Part III. Materials for drug delivery
-
14. Polymers as nanocarriers for controlled drug delivery
- Prof. Dr. Marcelo Calderón
-
15. Polymeric gels for drug delivery
- Dr. G. Roshan Deen
- Ms. Dora Safar
-
16. Liposomes as a drug delivery system
- Dr. G. Roshan Deen
- Ms. Bushra Hasan
- Ms. Renad AlAnsari
-
17. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)
- Prof. Ana Catarina Silva
-
18. Micellar drug delivery
- Prof. Francesco Cellesi
-
19. Nanocrystals in drug delivery
- Prof. Eliana Souto
-
20. Layer-by-layer assemblies for drug delivery
- Prof. Szczepan Zapotoczny
-
21. Inorganic nanostructured interfaces for therapeutic delivery
- Prof. Tejal Desai
-
22. Inorganic porous drug delivery carriers
- Prof. Jessica Rosenholm
- Part IV. Specifics of drug delivery
-
23. Delivery of genes and nucleotides
- Prof. Esam Yahya
-
24. Vaccine delivery
- Prof. Sevda Şenel
- Part V. Drug delivery in various diseases
-
25. Drug delivery for cancer therapeutics
- Prof. Tejraj Aminabhavi
-
26. Nanomedicines for brain diseases
- Prof. Giovanni Tosi
-
27. Drug delivery to the colon
- Prof. Susan Hua
-
28. Role of the lymphatic system in drug absorption
- Dr. Kishor M. Wasan
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Anatomy of the gastrointestinal tract
- Anatomy of the large intestine
- General principles of drug absorption
- Drug absorption
- Lipid solubility and drug absorption
- Sublingual and buccal routes for gastrointestinal drug delivery
- The sublingual and buccal route for drug delivery
- Advantages and disadvantages: the sublingual and buccal routes
- Physiological factors influencing drug delivery via sublingual and buccal routes
- Examples of clinically approved drugs
- Oral route for gastrointestinal drug delivery
- Oral route for drug delivery
- Advantages and disadvantages: oral route for drug delivery
- Issues with oral drug delivery
- Physiological factors influencing drug delivery via the oral route
- Gastrointestinal transit times
- Gastrointestinal pH
- Gastrointestinal mucus
- Intestinal fluid volume
- Enzymes in the gastrointestinal tract
- Microbial degradation in the gastrointestinal tract
- Impact of disease
- Impact of co-administered drugs
- Impact of gastrointestinal surgery
- Goals in oral formulation design
- Conventional dosage forms for oral drug delivery
- Regional drug targeting in the stomach
- Commercialised drug delivery systems
- Regional drug targeting in the small intestine
- Regional drug targeting in the colon
- pH-responsive delivery to the colon
- Time-dependent formulations
- Biodegradable dosage forms
- Prodrug-based approach
- Rectal route for gastrointestinal drug delivery
- Rectal route for drug delivery
- Advantages and disadvantages: rectal route for drug delivery
- Physiological factors influencing drug delivery via the rectal route: anatomy
- Physiological factors influencing drug delivery via the rectal route: site of drug absorption
- Physiological factors influencing drug delivery via the rectal route: others
- Examples of clinically approved drugs
- Conclusions
- Thank you
Topics Covered
- Anatomy of the gastrointestinal tract
- Principles of drug absorption in the gastrointestinal tract
- Physiological and pharmaceutical factors influencing drug delivery
- Routes for drug delivery in the gastrointestinal tract
- Drug targeting in the stomach, small intestine, and colon
Talk Citation
Hua, S. (2021, January 31). Gastrointestinal drug delivery [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/EWKF3655.Export Citation (RIS)
Publication History
Financial Disclosures
- Susan Hua has no commercial/financial relationships to disclose
A selection of talks on Pharmaceutical Sciences
Transcript
Please wait while the transcript is being prepared...
0:00
Hi, my name is Susan Hua,
and I'm an associate professor in the discipline of pharmacy and the head of
the therapeutic targeting research program at the University of Newcastle.
The focus of this lecture is on gastrointestinal drug delivery,
which will be considered both as a route for systemic drug delivery
and for treating local gastrointestinal diseases.
0:22
This slide shows an outline of the lecture.
Firstly, I will discuss the general anatomy of
the gastrointestinal tract, and
the general principles of drug absorption in the gastrointestinal tract.
This will be followed by a more detailed discussion on
the physiological and pharmaceutical considerations influencing drug delivery,
as well as the drug delivery approaches for each
of the main routes for gastrointestinal drug delivery.
0:44
The gastrointestinal tract, or GI tract,
is a muscular tube that is approximately nine meters in length with varying diameters.
The gastrointestinal tract is divided into the upper and lower tract.
The upper gastrointestinal tract consists of the mouth, pharynx,
esophagus, stomach, and the first part of the small intestine,
also known as the duodenum.
The lower gastrointestinal tract includes the other parts of the small intestine,
that is the jejunum and ileum, and all of the large intestine.
1:12
The large intestine is the distal part of
the gastrointestinal tract and has three main segments,
the cecum, the colon, and the rectum.
The colon can be divided into four parts;
ascending, transverse, descending, and sigmoid.
The main functions of the gastrointestinal tract are the digestion of food,
absorption of nutrients, and excretion of waste products.
The gastrointestinal tract is also a common route for drug administration,
with the main routes being sublingual,
buccal, oral, and rectal.
These routes will be the focus of this lecture on
gastrointestinal drug delivery as a route for drug administration.